Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients Throughout COVID-19 Vaccination Era

Overview

Journal Curr Pharm Des

Publisher Bentham Science Publishers

Date 2024 Mar 8

PMID 38454762

Authors

Alessia Giordano

Rosj Gallicchio

Mariarita Milella

Rebecca Storto

Anna Nardelli

Teresa Pellegrino

Antonio Nappi

Michele Di Cosola

Giovanni Storto

Affiliations

Soon will be listed here.

Abstract

Background: The unexpected detection of axillary lymphadenopathy (AxL) in cancer patients (pts) represents a real concern during the COVID-19 vaccination era. Benign reactions may take place after vaccine inoculation, which can mislead image interpretation in patients undergoing F-18-FDG, F-18-Choline, and Ga-68-DOTATOC PET/CT. They may also mimic loco-regional metastases or disease. We assessed PET/CT findings after COVID-19 first dose vaccination in cancer patients and the impact on their disease course management.

Methods: We evaluated 333 patients undergoing PET/CT (257 F-18-FDG, 54 F-18-Choline, and 23 Ga-68 DOTATOC) scans after the first vaccination with mRNA vaccine (Pfizer-BioNTech) (study group; SG). The uptake index (SUVmax) of suspected AxL was defined as significant when the ratio was > 1.5 as compared to the contralateral lymph nodes. Besides, co-registered CT (Co-CT) features of target lymph nodes were evaluated. Nodes with aggregate imaging positivity were further investigated.

Results: Overall, the prevalence of apparently positive lymph nodes on PET scans was 17.1% during the vaccination period. 107 pts of the same setting, who had undergone PET/CT before the COVID-19 pandemic, represented the control group (CG). Only 3 patients of CG showed reactive lymph nodes with a prevalence of 2.8% (p < 0.001 as compared to the vaccination period). 84.2% of SG patients exhibited benign characteristics on co-CT images and only 9 pts needed thorough appraisal.

Conclusion: The correct interpretation of images is crucial to avoid unnecessary treatments and invasive procedures in vaccinated cancer pts. A detailed anamnestic interview and the analysis of lymph nodes' CT characteristics, after performing PET/CT, may help to clear any misleading diagnosis.

References

Viscusi W . Pricing the global health risks of the COVID-19 pandemic. J Risk Uncertain. 2020; 61(2):101-128. PMC: 7604649. DOI: 10.1007/s11166-020-09337-2. View

Jablonska K, Aballea S, Toumi M . The real-life impact of vaccination on COVID-19 mortality in Europe and Israel. Public Health. 2021; 198:230-237. PMC: 8413007. DOI: 10.1016/j.puhe.2021.07.037. View

Su S, Du L, Jiang S . Learning from the past: development of safe and effective COVID-19 vaccines. Nat Rev Microbiol. 2020; 19(3):211-219. PMC: 7566580. DOI: 10.1038/s41579-020-00462-y. View

Fanciullino R, Ciccolini J, Milano G . COVID-19 vaccine race: watch your step for cancer patients. Br J Cancer. 2020; 124(5):860-861. PMC: 7720437. DOI: 10.1038/s41416-020-01219-3. View

Ahn R, Mootz A, Brewington C, Abbara S . Axillary Lymphadenopathy After mRNA COVID-19 Vaccination. Radiol Cardiothorac Imaging. 2021; 3(1):e210008. PMC: 7861140. DOI: 10.1148/ryct.2021210008. View

McIntosh L, Bankier A, Vijayaraghavan G, Licho R, Rosen M . COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management. AJR Am J Roentgenol. 2021; 217(4):975-983. DOI: 10.2214/AJR.21.25728. View

Seely J . Correction to: The Canadian Society of Breast Imaging/Canadian Association of Radiologists' Recommendations for the Management of Axillary Adenopathy in Patients With Recent COVID-19 Vaccination. Can Assoc Radiol J. 2021; 73(2):432. DOI: 10.1177/08465371211029086. View

Lehman C, DAlessandro H, Mendoza D, Succi M, Kambadakone A, Lamb L . Unilateral Lymphadenopathy After COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties. J Am Coll Radiol. 2021; 18(6):843-852. PMC: 7931722. DOI: 10.1016/j.jacr.2021.03.001. View

Storto G, Nicolai E, Salvatore M . [18F]FDG-PET-CT for early monitoring of tumor response: when and why. Q J Nucl Med Mol Imaging. 2009; 53(2):167-80. View

10.

Storto G, De Renzo A, Pellegrino T, Perna F, De Falco T, Erra P . Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. Radiology. 2009; 254(1):245-52. DOI: 10.1148/radiol.09090603. View

11.

Treglia G . Diagnostic Performance of F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses. Contrast Media Mol Imaging. 2019; 2019:3018349. PMC: 6683817. DOI: 10.1155/2019/3018349. View

12.

Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A . State of the art of F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging. 2021; 9(4):299-339. PMC: 8271312. DOI: 10.1007/s40336-021-00445-w. View

13.

Oprea-Lager D, Vincent A, van Moorselaar R, Gerritsen W, van den Eertwegh A, Eriksson J . Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer. PLoS One. 2012; 7(10):e48430. PMC: 3485217. DOI: 10.1371/journal.pone.0048430. View

14.

Weiler-Sagie M, Half E . [Ga]Ga-DOTA-TATE uptake due to COVID-19 vaccination. Eur J Nucl Med Mol Imaging. 2021; 48(11):3743-3744. PMC: 8139867. DOI: 10.1007/s00259-021-05414-z. View

15.

Thomassen A, Nielsen A, Gerke O, Johansen A, Petersen H . Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination. Eur J Nucl Med Mol Imaging. 2011; 38(5):894-8. DOI: 10.1007/s00259-011-1729-9. View

16.

Smith M, Yang M . Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on F-FDG PET/CT. J Nucl Med Technol. 2021; 49(3):286-287. PMC: 8712634. DOI: 10.2967/jnmt.121.262008. View

17.

Nawwar A, Searle J, Hopkins R, Lyburn I . False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization. Clin Nucl Med. 2021; 46(12):1004-1005. PMC: 8575105. DOI: 10.1097/RLU.0000000000003657. View

18.

Schroeder D, Jang S, Johnson D, Takahashi H, Navin P, Broski S . Frequency and Characteristics of Nodal and Deltoid FDG and C-Choline Uptake on PET Performed After COVID-19 Vaccination. AJR Am J Roentgenol. 2021; 217(5):1206-1216. DOI: 10.2214/AJR.21.25928. View

19.

Eifer M, Eshet Y . Imaging of COVID-19 Vaccination at FDG PET/CT. Radiology. 2021; 299(2):E248. PMC: 7845454. DOI: 10.1148/radiol.2020210030. View

20.

Cocco G, Delli Pizzi A, Fabiani S, Cocco N, Boccatonda A, Frisone A . Lymphadenopathy after the Anti-COVID-19 Vaccine: Multiparametric Ultrasound Findings. Biology (Basel). 2021; 10(7). PMC: 8301414. DOI: 10.3390/biology10070652. View